Biotech Values

[DewDiligence]

GTCB partnership update:

--The $2M up-front fee from LEO is non-refundable. Although this amount is small, it’s nice that LEO is sufficiently confident in ATryn’s timely approval that it is willing to take the risk.

--More details on the partnership agreement will be made available in future SEC filings.

--Some discussion of the partnership agreement will take place on GTC’s quarterly CC tomorrow morning (10:00 a.m. ET).

Source: Tom Newberry